Harvard research on epigenetic reprogramming and aging-related disease reversal

Harvard researcher David Sinclair advocates for the theory that aging is an epigenetic process that can be reversed to eliminate age-related diseases. While the research into epigenetic reprogramming shows promise in laboratory models, the clinical efficacy and safety of these interventions in humans remain unproven.